Skip to content

Imaging of Ventricular Reversed Remodeling after Double Lung Transplantation in Patients with Pulmonary Arterial Hypertension

Imaging of Ventricular Reversed Remodeling after Double Lung Transplantation in Patients with Pulmonary Arterial Hypertension - Ventricular reversed remodeling after LTX in patients with PAH

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON41137
Enrollment
20
Registered
2014-07-23
Start date
2015-04-28
Completion date
Unknown
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

high blood pressure pulmonary artery Idiopathic/primary pulmonary arterial hypertension

Interventions

None listed

Sponsors

Universitair Medisch Centrum Groningen
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Primary study group: - Patients who are on the waiting list for double-LTX, in our institution, for pulmonary arterial hypertension - Eligible for CMR imaging - No claustrophobia - No pacemaker, ICD, etc. - Informed consent;Control group: - Patients who are on the waiting list for double-LTX, in our institution. - Echocardiographic evaluation including an estimation of RV peak pressure,

Exclusion criteria

Exclusion criteria: - Inability to comply with primary endpoint measures. - Body mass index >40 kg/m2. - Pregnant patients will not be included, they may be included >3 months after pregnancy. - Patients with age

Design outcomes

Primary

MeasureTime frame
Right ventricular remodeling measured on cardiac magnetic resonance (CMR) imaging after LTX will be investigated in terms of: 1) RV mass, trabecularisation and extracellular matrix composition; 2) geometry and septal configuration; 3) radial, circumferential and longitudinal deformation. Left ventricular remodeling comprises function, geometry and mass.

Secondary

MeasureTime frame
Functional parameters on echocardiography, disease specific electrophysiological findings on electrocardiography (ECG) and N-terminal probrain natriuretic peptide (NT pro-BNP) level.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)